Co-founder and CEO of 21 Impact Labs and the developer of the soon-to-be-released Xponetiq app for optimizing brain potential. Serial entrepreneur, Co-Founder and CEO/COO of multiple software startups, Brian has successfully raised multiple rounds of VC/PE capital and bought and sold businesses, including the exit of a $340m software startup to a publicly traded company. A passionate advocate for brain health, he is driven by his youngest daughter, who has Down syndrome, to accelerate solutions and cures for Alzheimer’s disease.
Liwaa has over 9 years of experience in the financial industry, as well as with over 7 years of experience in blockchain and cryptocurrency since 2016. He has worked on projects of varying scales and companies ranging from crypto startups to the biggest bank in the UAE, First Abu Dhabi Bank (FAB). Liwaa is a certified blockchain expert with a master's degree in Crypto & Blockchain from the University of Nicosia (UNIC).
Maryna uses neuroimaging, neuropsychological testing, and machine learning to improve early diagnostics of PPA. She works at the Foresight Institute, leading the Neurotech Tree project as they build a new roadmap for the future of neurotechnology. She is also a lecturer at HTW Berlin and the University of Leipzig and Max-Planck Research School, where she teaches an introduction to medicine, with a focus on digital health.